The immunogenic part of infliximab is the F(ab′)2, but measuring antibodies to the intact infliximab molecule is more clinically useful

Shomron Ben-Horin*, Miri Yavzori, Lior Katz, Uri Kopylov, Orit Picard, Ella Fudim, Daniel Coscas, Simon Bar-Meir, Itamar Goldstein, Yehuda Chowers

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

195 Scopus citations

Fingerprint

Dive into the research topics of 'The immunogenic part of infliximab is the F(ab′)2, but measuring antibodies to the intact infliximab molecule is more clinically useful'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology